🇺🇸 FDA
Pipeline program

ALDESLEUKIN , Tumor Intiltrating Lymphocytes (TIL) – VHIO, FLUDARABINE , CYCLOPHOSPHAMIDE

Phase 2 small_molecule active

Quick answer

ALDESLEUKIN , Tumor Intiltrating Lymphocytes (TIL) – VHIO, FLUDARABINE , CYCLOPHOSPHAMIDE for Germ Cell Tumors refractory to salvage chemotherapy is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Germ Cell Tumors refractory to salvage chemotherapy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials